Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion description "[We speculate that engineering GLP-1-Gly8 secretion by beta-cells is a potential gene therapeutic strategy to treat diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion evidence source_evidence_literature NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion SIO_000772 15642594 NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion wasDerivedFrom befree-2016 NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_assertion wasGeneratedBy ECO_0000203 NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.
- befree-2016 importedOn "2016-02-19" NP475664.RAhQ2F6Bj7n88XZQ_rWyoCdcNIQ0E0k9F7eT4P4q3a7so130_provenance.